Search Results

Search for "Dactinomycin" returned 2 results

Showing 1-2 out of 2

DrugBank ID	Name	Formula	Weight
DB00970	Dactinomycin	C₆₂H₈₆N₁₂O₁₆	1255.4170
DB00970	However, the toxic properties of the actinomycins (including dactinomycin) in relation to antibacterial activity are such as to preclude their use as antibiotics in the treatment of infectious ...
DB00072	Trastuzumab	C₆₄₇₀H₁₀₀₁₂N₁₇₂₆O₂₀₁₃S₄₂	145531.5000
DB00072	Monitor closely for signs and symptoms of adverse events. Dactinomycin Trastuzumab may increase the risk of neutropenia and anemia. Monitor closely for signs and symptoms of adverse events.

Showing 1-2 out of 2

This project is supported by Genome Alberta & Genome Canada, a not-for-profit organization that is leading Canada's national genomics strategy with $600 million in funding from the federal government. This project is also supported in part by GenomeQuest, Inc., an enterprise genomic information company serving the life science community.